Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC N-(1,3-diphenyl-1H-pyrazol-5-yl)-4-nitrobenzamide | 890764-36-0 | MFCD12546140 | 99.6% | 384.39 g/mol | C22H16N4O3 | 25 MG
SDP

Catalog No. 5000241327
Encompass_Preferred

VU-29 (N-(1,3-diphenyl-1H-pyrazol-5-yl)-4-nitrobenzamide, CAS 890764-36-0) is a research small molecule that acts as a positive allosteric modulator of the metabotropic glutamate receptor 5 (mGlu5). Supplied as a high-purity solid, it is intended for use in in vitro and in vivo pharmacology and neuroscience research.

  • Acts as a positive allosteric modulator of mGlu5 receptor.
  • High purity suitable for research applications.
  • Solid form for convenient handling and storage.
  • Available in small mass packages for preclinical studies.
  • Characterized by standard chemical identifiers for traceability.

Catalog No. 50-002-41327 Supplier Medchemexpress LLC Supplier No. HY10750825MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

VU-29 (N-(1,3-diphenyl-1H-pyrazol-5-yl)-4-nitrobenzamide, CAS 890764-36-0) is a research small molecule that acts as a positive allosteric modulator of the metabotropic glutamate receptor 5 (mGlu5). Supplied as a high-purity solid, it is intended for use in in vitro and in vivo pharmacology and neuroscience research.

  • Acts as a positive allosteric modulator of mGlu5 receptor.
  • High purity suitable for research applications.
  • Solid form for convenient handling and storage.
  • Available in small mass packages for preclinical studies.
  • Characterized by standard chemical identifiers for traceability.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.